share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

辉瑞 | 4：持股变动声明
SEC announcement ·  04/01 19:38
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 03/28/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was conducted under the issuer name and trading symbol PFIZER INC [PFE].
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 03/28/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was conducted under the issuer name and trading symbol PFIZER INC [PFE].
辉瑞公司（PFE）董事长兼首席执行官阿尔伯特·布拉于2024年3月28日执行了一项交易。公告中未披露交易的具体细节，包括交易的股票数量、股票的性质、交易价格和股票的总价值。该报告也没有提供有关Bourla在交易后持有的股票数量的信息。该交易以发行人的名称和交易代码辉瑞公司 [PFE] 进行。
辉瑞公司（PFE）董事长兼首席执行官阿尔伯特·布拉于2024年3月28日执行了一项交易。公告中未披露交易的具体细节，包括交易的股票数量、股票的性质、交易价格和股票的总价值。该报告也没有提供有关Bourla在交易后持有的股票数量的信息。该交易以发行人的名称和交易代码辉瑞公司 [PFE] 进行。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息